Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD

NCT07076290 is registered in ClinicalTrials.gov with Rise Therapeutics LLC as lead sponsor.

NCT NCT07076290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07076290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD
Lead sponsor
Rise Therapeutics LLC
Phase
Phase 1
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
December 31, 2028
Enrollment
27 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

copd (chronic obstructive pulmonary disease), copd exacerbation, copd exacerbation acute